Use of lepidylins in the treatment of nervous system cancer
PL250574B1Active Publication Date: 2026-11-16UNIWERSYTET MEDYCZNY W LUBLINIE
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- PL2023447378
- Authority / Receiving Office
- PL · PL
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2023-12-29
- Publication Date
- 2026-11-16
- Estimated Expiration
- 2043-12-29
Smart Images

Figure 00000006_0000 
Figure 00000006_0001 
Figure 00000007_0000
Abstract
The purpose of the invention is to use lepidyllins B, C, and D for anticancer activity. The invention provides lepidyllins B, C, and D with molecular formulas of C20H23ClN2, C20H23ClN2O, and C21H25ClN2O, respectively, as imidazole alkaloid compounds for use in the treatment of nervous system cancer, preferably neuroblastoma. The invention provides the opportunity to utilize the anticancer activity of lepidyllins B, C, and D and use them as potential drugs or pharmaceutical ingredients in the pharmaceutical industry for the treatment of patients with nervous system cancer, particularly neuroblastoma.
Need to check novelty before this filing date? Find Prior Art
